Article

Pharmacogenomics: Ethical and Regulatory Issues

Matthew Decamp and Allen Buchanan

in The Oxford Handbook of Bioethics

Published in print February 2009 | ISBN: 9780199562411
Published online September 2009 | | DOI: http://dx.doi.org/10.1093/oxfordhb/9780199562411.003.0024

Series: Oxford Handbooks in Philosophy

 Pharmacogenomics: Ethical and Regulatory Issues

More Like This

Show all results sharing these subjects:

  • Philosophy
  • Philosophy of Science
  • Moral Philosophy

GO

Show Summary Details

Preview

While acknowledging the potential benefits of pharmacogenomics as a methodology, a number of comprehensive reports in the past several years examine a multitude of ethical, legal, and social factors that may limit the extent to which these benefits are realized — and realized in ethically acceptable ways. This article aims to identify and explore the most basic ethical and regulatory issues that are likely to arise if pharmacogenomics becomes widely enough used to have a significant impact on research and clinical practice. First, however, it addresses the question of whether pharmacogenomic tests are unique when compared to other genetic tests and thus deserving of more or less stringent ethical and regulatory requirements.

Keywords: pharmacogenomics; social factors; clinical practice; genetic tests; pharmacogenomic tests; ethical requirements

Article.  14445 words. 

Subjects: Philosophy ; Philosophy of Science ; Moral Philosophy

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.